BlackRock’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-124,734
| Closed | -$36.2K | – | 5543 |
|
|
2025
Q1 | $36.2K | Hold |
124,734
| – | – | ﹤0.01% | 4935 |
|
|
2024
Q4 | $52.4K | Hold |
124,734
| – | – | ﹤0.01% | 4882 |
|
|
2024
Q3 | $59.2K | Hold |
124,734
| – | – | ﹤0.01% | 4726 |
|
|
2024
Q2 | $64.6K | Sell |
124,734
-61,214
| -33% | -$31.7K | ﹤0.01% | 4752 |
|
|
2024
Q1 | $146K | Sell |
185,948
-75,068
| -29% | -$59K | ﹤0.01% | 4591 |
|
|
2023
Q4 | $765K | Buy |
261,016
+2,515
| +1% | +$7.37K | ﹤0.01% | 4249 |
|
|
2023
Q3 | $584K | Sell |
258,501
-2,478
| -0.9% | -$5.6K | ﹤0.01% | 4316 |
|
|
2023
Q2 | $561K | Buy |
260,979
+109,666
| +72% | +$236K | ﹤0.01% | 4369 |
|
|
2023
Q1 | $334K | Buy |
151,313
+894
| +0.6% | +$1.98K | ﹤0.01% | 4561 |
|
|
2022
Q4 | $165K | Buy |
150,419
+596
| +0.4% | +$654 | ﹤0.01% | 4818 |
|
|
2022
Q3 | $205K | Sell |
149,823
-6,216
| -4% | -$8.51K | ﹤0.01% | 4876 |
|
|
2022
Q2 | $272K | Sell |
156,039
-373,515
| -71% | -$651K | ﹤0.01% | 4862 |
|
|
2022
Q1 | $1.06M | Buy |
529,554
+109,226
| +26% | +$219K | ﹤0.01% | 4558 |
|
|
2021
Q4 | $1.88M | Sell |
420,328
-929
| -0.2% | -$4.14K | ﹤0.01% | 4358 |
|
|
2021
Q3 | $2.53M | Buy |
421,257
+1,468
| +0.3% | +$8.82K | ﹤0.01% | 4161 |
|
|
2021
Q2 | $4.71M | Buy |
419,789
+74,483
| +22% | +$835K | ﹤0.01% | 3839 |
|
|
2021
Q1 | $5.73M | Buy |
345,306
+13,274
| +4% | +$220K | ﹤0.01% | 3816 |
|
|
2020
Q4 | $8.07M | Buy |
+332,032
| New | +$8.07M | ﹤0.01% | 3414 |
|